Fasting glucose-to-HDL cholesterol ratio and risk of MASLD in nonobese Chinese adults: A retrospective cohort study

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized in nonobese individuals; however, reliable markers for early risk identification remain limited. The fasting glucose-to-high-density lipoprotein cholesterol (FHR) ratio, which reflects integrated glucolipid metabolism, has emerged as a potential indicator. This study aimed to evaluate the association between FHR and the incidence of MASLD in nonobese adults. This retrospective cohort study included 16,173 nonobese Chinese adults (body mass index < 25 kg/m2) from the Wenzhou Health Examination Cohort. Participants without MASLD at baseline were categorized into quartiles according to their FHR levels. Incident MASLD was diagnosed using abdominal ultrasonography during follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) after adjusting for demographic, clinical, and metabolic factors. Dose-response relationships were assessed using restricted cubic spline models, and receiver operating characteristic (ROC) analysis was performed to evaluate predictive performance. During follow-up, 2322 participants developed MASLD. Higher FHR levels were significantly associated with an increased risk of MASLD. In the fully adjusted model, each 1-unit increase in FHR was associated with a 22% higher risk of MASLD (HR, 1.22; 95% CI: 1.17-1.27, P < .001). Compared to the lowest quartile, the highest quartile showed a significantly elevated risk (HR: 2.10, 95% CI: 1.78-2.48; P for trend < 0.001). A positive dose-response relationship was also observed. ROC analysis showed that FHR had a moderate predictive ability (AUC, 0.701; 95% CI, 0.690 to 0.713), with an optimal cutoff value of 3.87. Elevated FHR was independently associated with an increased risk of MASLD in nonobese Chinese adults. Thus, FHR may serve as a simple and cost-effective biomarker for early risk stratification in this population.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-06
DOI
https://doi.org/10.1097/md.0000000000051474
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fasting glucose-to-HDL cholesterol ratio and risk of MASLD in nonobese Chinese adults: A retrospective cohort study

Zhijie Zhuang, Danfeng Gong, Jian Luo, Fang Yi et al.
9 links
Medicine
Liver Disease Diagnosis and Treatment
article

Fasting glucose-to-HDL cholesterol ratio and risk of MASLD in nonobese Chinese adults: A retrospective cohort study

Zhijie Zhuang, Danfeng Gong, Jian Luo, Fang Yi, Yingzhu Xiong, Xueyan Wu, Haifeng Zhou, Liqun Nie
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized in nonobese individuals; however, reliable markers for early risk identification remain limited. The fasting glucose-to-high-density lipoprotein cholesterol (FHR) ratio, which reflects integrated glucolipid metabolism, has emerged as a potential indicator. This study aimed to evaluate the association between FHR and the incidence of MASLD in nonobese adults. This retrospective cohort study included 16,173 nonobese Chinese adults (body mass index < 25 kg/m2) from the Wenzhou Health Examination Cohort. Participants without MASLD at baseline were categorized into quartiles according to their FHR levels. Incident MASLD was diagnosed using abdominal ultrasonography during follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) after adjusting for demographic, clinical, and metabolic factors. Dose-response relationships were assessed using restricted cubic spline models, and receiver operating characteristic (ROC) analysis was performed to evaluate predictive performance. During follow-up, 2322 participants developed MASLD. Higher FHR levels were significantly associated with an increased risk of MASLD. In the fully adjusted model, each 1-unit increase in FHR was associated with a 22% higher risk of MASLD (HR, 1.22; 95% CI: 1.17-1.27, P < .001). Compared to the lowest quartile, the highest quartile showed a significantly elevated risk (HR: 2.10, 95% CI: 1.78-2.48; P for trend < 0.001). A positive dose-response relationship was also observed. ROC analysis showed that FHR had a moderate predictive ability (AUC, 0.701; 95% CI, 0.690 to 0.713), with an optimal cutoff value of 3.87. Elevated FHR was independently associated with an increased risk of MASLD in nonobese Chinese adults. Thus, FHR may serve as a simple and cost-effective biomarker for early risk stratification in this population.

MedicineVol. 105(45)
Central South University (CN), The First People's Hospital of Changde (CN)
Good health and well-being
Openalex Percentile: Top 17%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon